Multiplicity in randomised trials I: endpoints and treatments.
Multiplicity problems emerge from investigators looking at many additional endpoints and treatment group comparisons. Thousands of potential comparisons can emanate from one trial. Investigators might only report the significant comparisons, an unscientific practice if unwitting, and fraudulent if i...
| Publicado en: | Lancet Vol. 365; no. 9470; pp. 1591 - 1596 |
|---|---|
| Autores principales: | , , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Lancet
4/30/2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |